Jan Kaiserle

The burgeoning market for GLP-1 weight-loss medications created a gold rush for telehealth companies, but for Hims & Hers, a bold move into this lucrative space has rapidly devolved into a multi-front battle with regulators and pharmaceutical giants. The company's recent announcement that it would

A groundbreaking study offers a novel strategy in the relentless fight against neurodegeneration by borrowing one of modern oncology's most powerful weapons and turning it against the pathologies of the brain. The research demonstrates, for the first time in a living animal model, that an

A single rogue protein, present in nearly every person diagnosed with amyotrophic lateral sclerosis, has long been the focus of intense scientific pursuit and a major roadblock to effective treatment. Netherlands-based biotechnology company VectorY Therapeutics has now initiated a landmark clinical

An experimental oral medication for obesity has delivered substantial weight loss in a mid-stage trial, heralding the arrival of a formidable new challenger in a market dominated by pharmaceutical titans. Co-developed by Hengrui Pharma and Kailera Therapeutics, the pill, known as ribupatide,

The long-held view of enzymes as nature's exquisitely specific but single-minded catalysts is undergoing a profound transformation, giving way to a new paradigm that reimagines them as versatile, programmable molecular machines. This significant shift, fueled by remarkable discoveries in natural

The landscape of laboratory research is undergoing a profound transformation, moving away from siloed operations and toward a future defined by intelligent, interconnected automation. At the upcoming SLAS 2026 conference in Boston, ABB Robotics is set to demonstrate a significant leap forward in

The ambitious journey of bringing a groundbreaking therapy from a laboratory concept to a patient-ready treatment is increasingly intersecting with the harsh realities of a complex and fragmented manufacturing landscape. As biopharmaceutical innovators pioneer increasingly sophisticated molecules,

We're joined today by Biopharma expert Ivan Kairatov, whose work sits at the intersection of technology and research and development. We'll be discussing groundbreaking new research that is shattering the long-held, simplistic view of the vaginal microbiome. This conversation will explore how a

In the critical moments following a catastrophic injury, the difference between life and death is often measured not in minutes, but in milliliters of blood lost before a patient ever reaches the emergency room. For decades, first responders have navigated this uncertainty with limited tools,

Today we're joined by Ivan Kairatov, a biopharma expert with extensive experience in research and development. We'll be exploring the outcomes of a groundbreaking clinical trial that has identified a surprising new use for an old drug, offering significant relief to men undergoing hormone therapy